Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
March 28, 2022 | White Papers and Resources |
Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor …
Brought to you by M3 (EU)
March 24, 2022 | White Papers and Resources |
Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.
Brought to you by Say Communications
March 21, 2022 | White Papers and Resources |
What advisors and participants have to say about the Impetus InSite Platform!
Brought to you by Impetus Digital
March 21, 2022 | White Papers and Resources |
Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part …
Brought to you by M3 (EU)
March 17, 2022 | White Papers and Resources |
With increasing drug prices, what is the true cost to society? (Article written 2nd December 2020)
Brought to you by Dice Medical Communications
March 17, 2022 | White Papers and Resources |
How to write effectively in Pharma (Article written October 2021)
Brought to you by Dice Medical Communications
March 14, 2022 | White Papers and Resources |
For this Pre-Product Launch Longitudinal Expert Engagement Plan™ (LEEP™), our client leveraged Impetus Digital’s cutting-edge virtual tools, comprehensive online platform, and White-Glove™ digital and strategic …
Brought to you by Impetus Digital
March 14, 2022 | White Papers and Resources |
In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors …
Brought to you by M3 (EU)
March 10, 2022 | White Papers and Resources |
Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study
Brought to you by Innovative Trials
March 8, 2022 | White Papers and Resources |
More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of …
Brought to you by M3 (EU)